An article about medication effectiveness and side effects is circulating in the media. A piece by Shankar Vedantam appeared on the front page above the fold of today’s Washington Post. The article highlights some of the disagreements that have arisen between leading scientists over a follow-up to the landmark Multimodal Treatment Study on AD/HD. We encourage concerned parents to learn more by perusing the CHADD website and the website of CHADD’s National Resource Center on AD/HD. As always, parents should consult with their treatment and prescribing professionals before making any decisions about the treatment of AD/HD. Any treatment, including treatment of AD/HD, must be individualized to meet the unique circumstances of the person and his or her family.
You can read this blog and others like it at the HealthCentral website.